太空智造(300344.SZ):就申请向特定对象发行股票 收到深交所二次审核问询函
格隆汇 1 月 4日丨太空智造(300344.SZ)公布,公司于2020 年12月31日收到深圳证券交易所(“深交所”)出具的《关于太空智造股份有限公司申请向特定对象发行股票的第二轮审核问询函》(审核函〔2020〕020388 号),深交所发行上市审核机构对公司提交的向特定对象发行股票申请文件进行了审核,并形成了审核问询问题。
公司将按照《二次审核问询函》的要求,会同相关中介机构对所列问题逐项落实并及时提交对问询函的回复,回复内容将通过临时公告方式披露,并在披露后通过深交所发行上市审核业务系统报送相关文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.